{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:00:23Z","timestamp":1790388023338,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibroblast growth factor-21 (FGF21) is closely related to various metabolic and cardiovascular disorders. However, the direct targets and mechanisms linking FGF21 to blood pressure control and hypertension are still elusive. Here we demonstrated a novel regulatory function of FGF21 in the baroreflex afferent pathway (the nucleus tractus solitarii, NTS; nodose ganglion, NG). As the critical co-receptor of FGF21, \u03b2-klotho (klb) significantly expressed on the NTS and NG. Furthermore, we evaluated the beneficial effects of chronic intraperitoneal infusion of recombinant human FGF21 (rhFGF21) on the dysregulated systolic blood pressure, cardiac parameters, baroreflex sensitivity (BRS) and hyperinsulinemia in the high fructose-drinking (HFD) rats. The BRS up-regulation is associated with Akt-eNOS-NO signaling activation in the NTS and NG induced by acute intravenous rhFGF21 administration in HFD and control rats. Moreover, the expressions of FGF21 receptors were aberrantly down-regulated in HFD rats. In addition, the up-regulated peroxisome proliferator-activated receptor-\u03b3 and -\u03b1 (PPAR-\u03b3\/-\u03b1) in the NTS and NG in HFD rats were markedly reversed by chronic rhFGF21 infusion. Our study extends the work of the FGF21 actions on the neurocontrol of blood pressure regulations through baroreflex afferent pathway in HFD rats.<\/jats:p>","DOI":"10.1038\/srep29582","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T05:09:55Z","timestamp":1467954595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats"],"prefix":"10.1038","volume":"6","author":[{"given":"Jian-Li","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Xin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinian","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Fen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"BFsrep29582_CR1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246\u20131253 (2008).","journal-title":"Diabetes"},{"key":"BFsrep29582_CR2","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin, Z. et al. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation 131, 1861\u20131871 (2015).","journal-title":"Circulation"},{"key":"BFsrep29582_CR3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nm.3250","volume":"19","author":"BM Owen","year":"2013","unstructured":"Owen, B. M. et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat Med 19, 1153\u20131156 (2013).","journal-title":"Nat Med"},{"key":"BFsrep29582_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","volume":"25","author":"RE Gimeno","year":"2014","unstructured":"Gimeno, R. E. & Moller, D. E. FGF21-based pharmacotherapy\u2013potential utility for metabolic disorders. Trends Endocrinol Metab 25, 303\u2013311 (2014).","journal-title":"Trends Endocrinol Metab"},{"key":"BFsrep29582_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1172\/JCI67353","volume":"124","author":"B Emanuelli","year":"2014","unstructured":"Emanuelli, B. et al. Interplay between FGF21 and insulin action in the liver regulates metabolism. J Clin Invest 124, 515\u2013527 (2014).","journal-title":"J Clin Invest"},{"key":"BFsrep29582_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","volume":"23","author":"S Talukdar","year":"2016","unstructured":"Talukdar, S. et al. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. Cell Metab 23, 427\u2013440 (2016).","journal-title":"Cell Metab"},{"key":"BFsrep29582_CR7","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher, F. M. et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59, 2781\u20132789 (2010).","journal-title":"Diabetes"},{"key":"BFsrep29582_CR8","doi-asserted-by":"crossref","unstructured":"Benomar, Y. et al. Central Resistin\/TLR4 impairs adiponectin signaling contributing to insulin and FGF21 resistance. Diabetes, db151029 (2016).","DOI":"10.2337\/db15-1029"},{"key":"BFsrep29582_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","volume":"16","author":"X Ding","year":"2012","unstructured":"Ding, X. et al. \u03b2Klotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism. Cell Metab 16, 387\u2013393 (2012).","journal-title":"Cell Metab"},{"key":"BFsrep29582_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","volume":"25","author":"RE Gimeno","year":"2014","unstructured":"Gimeno, R. E. & Moller, D. E. FGF21-based pharmacotherapy - potential utility for metabolic disorders. Trends Endocrinol Metab 25, 303\u2013311 (2014).","journal-title":"Trends Endocrinol Metab"},{"key":"BFsrep29582_CR11","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya, Y. et al. FGF21 is an Akt-regulated myokine. FEBS Lett. 582, 3805\u20133810 (2008).","journal-title":"FEBS Lett."},{"key":"BFsrep29582_CR12","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1073\/pnas.1200797109","volume":"109","author":"W Wei","year":"2012","unstructured":"Wei, W. et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc Natl Acad Sci USA 109, 3143\u20133148 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep29582_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.20847","volume":"210","author":"JS Moyers","year":"2007","unstructured":"Moyers, J. S. et al. Molecular determinants of FGF\u201021 activity\u2014synergy and cross\u2010talk with PPAR\u03b3 signaling. J Cell Physiol 210, 1\u20136 (2007).","journal-title":"J Cell Physiol"},{"key":"BFsrep29582_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PaulA Dutchak","year":"2012","unstructured":"Dutchak, Paul A. et al. Fibroblast Growth Factor-21 Regulates PPAR\u03b3 Activity and the Antidiabetic Actions of Thiazolidinediones. Cell 148, 556\u2013567 (2012).","journal-title":"Cell"},{"key":"BFsrep29582_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM199602083340607","volume":"334","author":"GM Reaven","year":"1996","unstructured":"Reaven, G. M., Lithell, H. & Landsberg, L. Hypertension and Associated Metabolic Abnormalities \u2014 The Role of Insulin Resistance and the Sympathoadrenal System. N Engl J Med 334, 374\u2013382 (1996).","journal-title":"N Engl J Med"},{"key":"BFsrep29582_CR16","doi-asserted-by":"publisher","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","volume":"285","author":"JE Hall","year":"2010","unstructured":"Hall, J. E. et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin and melanocortins. J Biol Chem 285, 17271\u201317276 (2010).","journal-title":"J Biol Chem"},{"key":"BFsrep29582_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/jhh.2012.52","volume":"27","author":"RD Semba","year":"2013","unstructured":"Semba, R. D. et al. Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults. J Hum Hypertens 27, 397\u2013399 (2013).","journal-title":"J Hum Hypertens"},{"key":"BFsrep29582_CR18","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","volume":"28","author":"H Hsuchou","year":"2007","unstructured":"Hsuchou, H., Pan, W. & Kastin, A. J. The fasting polypeptide FGF21 can enter brain from blood. Peptides 28, 2382\u20132386 (2007).","journal-title":"Peptides"},{"key":"BFsrep29582_CR19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout, A. L. et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med 19, 1147\u20131152 (2013).","journal-title":"Nat Med"},{"key":"BFsrep29582_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/mp.2013.192","volume":"20","author":"Y Leng","year":"2015","unstructured":"Leng, Y. et al. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers. Mol Psychiatry 20, 215\u2013223 (2015).","journal-title":"Mol Psychiatry"},{"key":"BFsrep29582_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/01.HYP.15.4.397","volume":"15","author":"RD Bunag","year":"1990","unstructured":"Bunag, R. D., Eriksson, L. & Krizsan, D. Baroreceptor reflex impairment and mild hypertension in rats with dietary-induced obesity. Hypertension 15, 397\u2013406 (1990).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.RES.32.5.564","volume":"32","author":"AW Cowley Jr.","year":"1973","unstructured":"Cowley, A. W. Jr., Liard, J. F. & Guyton, A. C. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 32, 564\u2013576 (1973).","journal-title":"Circ Res"},{"key":"BFsrep29582_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.111.00156","volume":"61","author":"Z Shan","year":"2013","unstructured":"Shan, Z. et al. Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat. Hypertension 61, 1328\u20131333 (2013).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/HYPERTENSIONAHA.115.06815","volume":"67","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Unique Expression of Angiotensin Type-2 Receptor in Sex-Specific Distribution of Myelinated Ah-Type Baroreceptor Neuron Contributing to Sex-Dimorphic Neurocontrol of Circulation. Hypertension 67, 783\u2013791 (2016).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/157339906777950589","volume":"2","author":"I Skrapari","year":"2006","unstructured":"Skrapari, I., Tentolouris, N. & Katsilambros, N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Rev 2, 329\u2013338 (2006).","journal-title":"Curr Diabetes Rev"},{"key":"BFsrep29582_CR26","doi-asserted-by":"publisher","first-page":"H630","DOI":"10.1152\/ajpheart.00642.2001","volume":"282","author":"SD Beske","year":"2002","unstructured":"Beske, S. D., Alvarez, G. E., Ballard, T. P. & Davy, K. P. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 282, H630\u2013H635 (2002).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep29582_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.113.02272","volume":"63","author":"T-C Yeh","year":"2014","unstructured":"Yeh, T.-C. et al. Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling. Hypertension 63, 535\u2013541 (2014).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/HYPERTENSIONAHA.113.01847","volume":"63","author":"PS Guimaraes","year":"2014","unstructured":"Guimaraes, P. S. et al. Increasing Angiotensin-(1\u20137) Levels in the Brain Attenuates Metabolic Syndrome\u2013Related Risks in Fructose-Fed Rats. Hypertension 63, 1078\u20131085 (2014).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0002-9149(81)90333-7","volume":"48","author":"DS Goldstein","year":"1981","unstructured":"Goldstein, D. S. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol 48, 1147\u20131154 (1981).","journal-title":"Am J Cardiol"},{"key":"BFsrep29582_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.115.06329","volume":"67","author":"S-G Wei","year":"2016","unstructured":"Wei, S.-G., Yu, Y., Weiss, R. M. & Felder, R. B. Inhibition of Brain Mitogen-Activated Protein Kinase Signaling Reduces Central Endoplasmic Reticulum Stress and Inflammation and Sympathetic Nerve Activity in Heart Failure Rats. Hypertension 67, 229\u2013236 (2016).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/HYPERTENSIONAHA.109.138065","volume":"54","author":"AC Arnold","year":"2009","unstructured":"Arnold, A. C., Shaltout, H. A., Gallagher, P. E. & Diz, D. I. Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus. Hypertension 54, 1001\u20131008 (2009).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/HYPERTENSIONAHA.113.02057","volume":"63","author":"D Zhang","year":"2013","unstructured":"Zhang, D. et al. In Vivo Transfection of Manganese Superoxide Dismutase Gene or Nuclear Factor B shRNA in Nodose Ganglia Improves Aortic Baroreceptor Function in Heart Failure Rats. Hypertension 63, 88\u201395 (2013).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.HYP.36.6.1023","volume":"36","author":"K Sakai","year":"2000","unstructured":"Sakai, K. et al. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 36, 1023\u20131028 (2000).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1042\/cs0620589","volume":"62","author":"H Struyker-Boudier","year":"1982","unstructured":"Struyker-Boudier, H., Evenwel, R., Smits, J. & Van Essen, H. Baroreflex sensitivity during the development of spontaneous hypertension in rats. Clin. Sci. 62, 589\u2013594 (1982).","journal-title":"Clin. Sci."},{"key":"BFsrep29582_CR35","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1161\/01.CIR.0000145116.75657.2D","volume":"110","author":"HN Huang","year":"2004","unstructured":"Huang, H. N. et al. In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Circulation 110, 2476\u20132483 (2004).","journal-title":"Circulation"},{"key":"BFsrep29582_CR36","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1111\/j.1476-5381.2012.01832.x","volume":"166","author":"WH Cheng","year":"2012","unstructured":"Cheng, W. H. et al. Renin activates PI3K-Akt-eNOS signalling through the angiotensin AT(1) and Mas receptors to modulate central blood pressure control in the nucleus tractus solitarii. Br. J. Pharmacol. 166, 2024\u20132035 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep29582_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cmet.2014.01.021","volume":"19","author":"C Liu","year":"2014","unstructured":"Liu, C. et al. PPAR\u03b3 in Vagal Neurons Regulates High-Fat Diet Induced Thermogenesis. Cell Metab 19, 722\u2013730 (2014).","journal-title":"Cell Metab"},{"key":"BFsrep29582_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/HYPERTENSIONAHA.109.149146","volume":"55","author":"SHH Chan","year":"2010","unstructured":"Chan, S. H. H., Wu, K. L. H., Kung, P. S. S. & Chan, J. Y. H. Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-\u03b3 and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats. Hypertension 55, 1444\u20131453 (2010).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","volume":"20","author":"BM Owen","year":"2014","unstructured":"Owen, B. M. et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure and weight loss. Cell Metab 20, 670\u2013677 (2014).","journal-title":"Cell Metab"},{"key":"BFsrep29582_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/01.HYP.38.3.384","volume":"38","author":"ML Correia","year":"2001","unstructured":"Correia, M. L. et al. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 38, 384\u2013388 (2001).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/HYPERTENSIONAHA.115.05726","volume":"66","author":"Y Yu","year":"2015","unstructured":"Yu, Y. et al. Activation of Central PPAR-\u03b3 Attenuates Angiotensin II\u2013Induced Hypertension. Hypertension 66, 403\u2013411 (2015).","journal-title":"Hypertension"},{"key":"BFsrep29582_CR42","doi-asserted-by":"publisher","first-page":"C654","DOI":"10.1152\/ajpcell.00059.2009","volume":"297","author":"G-F Qiao","year":"2009","unstructured":"Qiao, G.-F., Li, B.-Y., Lu, Y.-J., Fu, Y.-L. & Schild, J. H. 17\u03b2-estradiol restores excitability of a sexually dimorphic subset of myelinated vagal afferents in ovariectomized rats. Am J Physiol Cell Physiol 297, C654\u2013C664 (2009).","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFsrep29582_CR43","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/CIRCRESAHA.109.208439","volume":"106","author":"WH Cheng","year":"2010","unstructured":"Cheng, W. H. et al. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1\/2-RSK signaling pathway to modulate central control of blood pressure. Circ Res 106, 788\u2013795 (2010).","journal-title":"Circ Res"},{"key":"BFsrep29582_CR44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3, 1101\u20131108 (2008).","journal-title":"Nat Protoc"},{"key":"BFsrep29582_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroscience.2015.06.049","volume":"303","author":"J Li","year":"2015","unstructured":"Li, J. et al. Sex-and afferent-specific differences in histamine receptor expression in vagal afferents of rats: A potential mechanism for sexual dimorphism in prevalence and severity of asthma. Neuroscience 303, 166\u2013177 (2015).","journal-title":"Neuroscience"},{"key":"BFsrep29582_CR46","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","volume":"29","author":"HE Covington","year":"2009","unstructured":"Covington, H. E. et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29, 11451\u201311460 (2009).","journal-title":"J Neurosci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep29582","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:50:40Z","timestamp":1672843840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep29582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep29582"],"URL":"https:\/\/doi.org\/10.1038\/srep29582","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]},"assertion":[{"value":"30 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29582"}}